Big Pharma firms work together on clinical databank

11/20/2012 | Pharmalot

Johnson & Johnson, Merck & Co. and Eli Lilly & Co. are pooling information about clinical investigators in an effort to speed the clinical trial process and avoid repeating one another's efforts. The databank will make information on investigators' clinical practice training available across the three firms, allowing investigators looking into a new indication or disease to forgo training at one firm if they have already had the appropriate training at another. Reducing the administrative burden will effectively expand the pool of investigators, said Dr. Andreas Koester, chief of clinical trial innovation at J&J unit Janssen Research & Development.

View Full Article in:

Pharmalot

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY